CN1560229A - Process of preparing D-amino acid oxydase - Google Patents

Process of preparing D-amino acid oxydase Download PDF

Info

Publication number
CN1560229A
CN1560229A CNA2004100168259A CN200410016825A CN1560229A CN 1560229 A CN1560229 A CN 1560229A CN A2004100168259 A CNA2004100168259 A CN A2004100168259A CN 200410016825 A CN200410016825 A CN 200410016825A CN 1560229 A CN1560229 A CN 1560229A
Authority
CN
China
Prior art keywords
amino
acid oxidase
enzyme
sudden change
daao
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004100168259A
Other languages
Chinese (zh)
Inventor
佩 周
周佩
冯美卿
史训龙
袁中一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fudan University
Original Assignee
Fudan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fudan University filed Critical Fudan University
Priority to CNA2004100168259A priority Critical patent/CN1560229A/en
Publication of CN1560229A publication Critical patent/CN1560229A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention is a method of preparing D-amino acid oxidase, relating to a method of preparing flavo-enzyme D-amino acid oxidase. Concretely, it relates to a method of highly efficiently producing mutational D-amino acid oxidase by constructing recombinant engineering strains. It reconstructs wild D-amino acid oxidase coming from Trigonopsis variablilis by means of gene engineering, fuses a segment of Histag at N end and C end of the wild enzyme, and further implements high-efficiency fast separation of mutational enzyme by affinity chromatography. The expression level of the enzyme in fermentation liquor is 4000IU/mL, higher than that of the wild enzyme, and the recovery ratio of Ni-column affinity chromatography is 50%. The purified enzyme can be used in making high-efficient oxidation conversion of cephalosporin C- to produce glutaryl-7-ACA and be used together with GL-7-ACA to produce 7-ACA.

Description

A kind of method for preparing the D-amino-acid oxidase
Technical field
The invention belongs to technical field of bioengineering, relate to a kind of method for preparing flavin protease D-amino-acid oxidase.Be specifically related to, by making up the method that recombinant strain obtains High-efficient Production sudden change D-amino-acid oxidase.
Background technology
D-amino-acid oxidase (D-Amino Acid Oxidase.EC 1.4.3.3.DAAO) is a kind of with the typical flavo-enzyme of flavin adenine dinucleotide (FAD) as prothetic group, extensively is present in animal and the multiple microorganism.Natural enzyme albumen is the dimer of 86kDa, has catalyzed oxidation cephalosporin vigor.Mammiferous DAAO combines pine with prothetic group FAD, prothetic group is easily lost and made enzyme deactivation; And that some yeast combines with prothetic group FAD is stronger, and greater activity is arranged.In the practical application, the DAAO of trigonopsis variabilis is that (Yeast 1997 for Dominguez, A, 13:1399-1408) for the most frequently used and tool application potential.DAAO catalysis D-amino-acid oxidase deamination generates alpha-ketoacid, can be used for the catalyzed oxidation dl aminoadipic acid and produces L-amino acid and alpha-ketoacid.In the enzyme process compound probability of semi-synthetic cynnematin, DAAO and GL-7ACA acylase double-enzyme catalysis are the present approach of the most promising Production by Enzymes 7-ACA.Cephalosporin produces α-ketone group hexanedioyl-7-amino-cephalosporanic acid through DAAO catalyzed oxidation deamination, if H is arranged 2O 2Exist, just the spontaneous oxidation decarboxylation form Glularyl-7-amino-cephalo-alkanoic acid (GL-7ACA) (Shewale, JG, J.Biotechnol.1999,75:11-22).The further catalysis GL-7ACA of GL-7-ACA acylase takes off glutaryl and generates 7-ACA.
At present, obtained the clone from the DAAO gene in multiple source, and in intestinal bacteria and yeast, realized recombinant expressed.Pichia yeast expression system has derivable strong promoter, can reach high-density culture and efficiently express, and is easy to realize industrialization.Report is arranged, and the DAAO that utilizes Pichia anomala expression to derive from trigonopsis variabilis Trigonopsis viabllis has obtained higher level and has expressed (Yuan Zhongyi, in building Chinese patent CN1385521A).Yet, find in the separation and purification process of DAAO, always to be accompanied by catalatic vigor, be difficult to realize the separation fully of the two with separating and purifying technology commonly used.
Summary of the invention
The purpose of this invention is to provide a kind of method for preparing the D-amino-acid oxidase simply, fast.Specifically be by making up the method that recombinant strain obtains High-efficient Production sudden change D-amino-acid oxidase.
The present invention adopts the DNA recombinant technology to transform trigonopsis variabilis wild-type DAAO gene, Histag is blended in the terminal and C-end of N-of wild-type enzyme gene, both realized efficiently expressing of mutant enzyme in pichia spp, available again affinity chromatography obtains highly purified DAAO quickly and easily.The enzyme of purifying can be used for efficient oxidation and transforms cephalosporin-generation glutaryl-7-ACA, can produce 7-ACA. with the coupling of GL-7-ACA acylase.
The present invention is undertaken by following method and step,
1, the sudden change daao gene,
With plasmid pPIC3.5K-DAAO is template, 5 ' end and 3 ' at the DAAO encoding sequence is held the Histag sequence that imports 6 Histidines of continuous programming code according to a conventional method respectively, obtain mutator gene, corresponding sudden change D-amino-acid oxidase N end and C end all have the Histidine sequence.Also can hold the Histag sequence that respectively be introduced separately into 6 Histidines at the 5 ' end or 3 ' of DAAO encoding sequence, corresponding sudden change D-amino-acid oxidase N end or C end have the Histidine sequence.
2, make up the mutant enzyme expression strain,
The said mutation gene is cloned into pBluescript (SK+) by flush end, cuts the carrier pPIC3.5K that rear clone is cut to same enzyme through NotI and BamHI enzyme again, obtains recombinant plasmid pPIC3.5K-hisDAAO.The SalI linearizing of described recombinant plasmid, electricity transforms pichia spp host cell GS115, obtain positive recombinant bacterial strain by the screening of PCR method, filter out superior strain by enzyme activity determination again, called after Fudan0112 is (in preservation on March 3 in 2004, depositary institution: CGMCC, the No. 13, North No.1 Row, Zhongguancun, Haidian District, Beijing City, deposit number: CGMCC No.1103, microorganism classification title: Pichia.Postori) s.
3, fermentation, cultivation, separation sudden change D-amino-acid oxidase,
After above-mentioned gained superior strain carried out fermentation culture, hold by sudden change D-amino-acid oxidase N end and C to have the affine fractionation by adsorption D-amino-acid oxidase of Ni ionic specificity on Histag sequence and the affine resin.The highest production of enzyme reaches 4000IU/ml.The thalline of gained through ultrasonic broken wall, low-temperature centrifugation gained supernatant as crude enzyme liquid, carry out affinity chromatography by the Ni post again, gradient is 0, the phosphoric acid buffer of 5mmol/L, 25mmol/L, 50mmol/L, 100mmol/L imidazoles, and the enzyme rate of recovery of purifying is 50%.
Host cell of the present invention is available from Invitrogen company, and gene source is in described bacterial strain of patent CN 1385521A and plasmid.
Description of drawings
Fig. 1 is the construction of recombinant plasmid figure that comprises the daao gene that suddenlys change of the present invention,
Fig. 2 is a SDS-PAGE electrophoretogram of the present invention: the intracellular protein of 1 positive reorganization bacterium wherein; 2 are albumen in the reorganization mycetocyte of empty carrier pPIC3.5k conversion; 3 is the lower molecular weight standard protein,
Fig. 3 is the vigor curve that pichia spp recombinant bacterial strain of the present invention is expressed the D-amino-acid oxidase,
Embodiment
Embodiment 1 obtains the sudden change daao gene
Codon design mutant primer according to the DAAO gene order of known trigonopsis variabilis Trigonopsis Vriabllis and Histidine correspondence is as follows:
5’primer?5’ GGATCC?ATGCACCATCATCATCATCAT?ATGGCTAAAA?TCGTTGTT
3 ' primer 5 ' GCGGCCGCTTAATGATGATGATGATGATG AAGGTTT GGACGAGTAAG templet gene derives from the described plasmid pPIC3.5K-DAAO of patent CN 1385521A, with high-fidelity PCR (Pfu enzyme, available from lottery industry) amplification DAAO gene, and 5 ' and 3 ' end at encoding sequence imports the Histag sequence of 6 Histidines of continuous programming code respectively respectively, and introduces the restriction enzyme site of NotI and BamHI correspondence respectively.The PCR reaction conditions is: 94 ℃ of 5min, 1 circulation; 94 ℃ of 30s, 40 ℃ of 30s, 72 ℃ of 75s, 5 circulations; 94 ℃ of 30s, 58 ℃ of 30s, 72 ℃ of 75s, 30 circulations; At last, 72 ℃ of 10min, 1 circulation.
The PCR product adopts DNA glue to reclaim test kit (available from Promega) and reclaims sudden change DAAO gene fragment after the checking of 1% agarose gel electrophoresis.
Embodiment 2 sudden change DAAO gene flush ends are cloned into plasmid pBluescript (SK+)
Plasmid pBluescript (SK+) is with the SmaI linearizing, as flush end clone's carrier.The sudden change DAAO gene fragment that glue reclaims is carried out external the connection with described carrier, and (20 μ l) is as follows for reaction system:
pBluescript(SK+) 2μl
PCR product 10 μ l
10 times connect damping fluid 2 μ l
T4 dna ligase (1U/ μ l) 1 μ l
Water 5 μ l
Mixture spends the night in 16 ℃ of reactions.Gained connects product Transformed E .coli TG1 competent cell, coats the LB flat board that contains ammonia benzyl resistance, selects white transformant extracting plasmid DNA, and gained DNA is pSK-DAAO with PCR method and enzyme cutting method proof recombinant plasmid.
Embodiment 3 construction expression plasmid pPIC3.5K-hisDAAO
With pSK-DAAO NotI and BamHI double digestion, 1% agarose gel electrophoresis, glue reclaims the fragment of about 1.3Kb, and the pPIC3.5K plasmid with the same double digestion of warp carries out external the connection again, and reaction system is as follows:
PPIC3.5k (NotI and BamHI cut) 2 μ l
DAAO gene segment 15 μ l
10x connects damping fluid 2 μ l
T4 dna ligase 1 μ
Said mixture spends the night in 16 ℃ of reactions.Gained connects product Transformed E .coli TG1 competent cell, coats the LB flat board that contains ammonia benzyl resistance, selects transformant extracting plasmid DNA, and gained DNA is pPIC3.5K-DAAO with PCR method and enzyme cutting method proof recombinant plasmid.
Embodiment 4 expression plasmids electricity transforms pichia spp GS115
Constructed expression plasmid pPIC3.5k-DAAO Sa/I linearization for enzyme restriction.It is 1.6-1.8 that host bacterium P.pastorisGS115 (his mut+) is cultured to OD; preparation electroreception attitude cell; mix with above-mentioned plasmid; transform voltage 1500V wherein, electric capacity 50 μ F again with GIBCOL BRL electricity conversion instrument CELL-PORATOR electricity; resistance 4k Ω; add the cold sorbyl alcohol of 0.5ml 1mol/L in transforming cup, get 200 μ l and be applied to the MD flat board, 30 ℃ are cultured to single bacterium colony and occur.Transformant is applied to MM and MD plate screening Mut+ transformant respectively, screens positive strain, the positive strain that obtains is expressed with PCR, sieve superior strain, wherein PDH12 strain expression level is the highest.
Embodiment 5 PCR method are screened positive pichia spp recombinant bacterial strain
Transformant on the MD flat board is inserted 3ml YPD test tube respectively cultivate, press yeast plasmid DNA extraction agent box and extract the transformant plasmid DNA.Do the PCR reaction by following PCR reaction system:
10X damping fluid 2.5 μ l
dNTP(25mM?each) 0.5μl
5’DAAO?Primer 1μl
3’DAAO?Primer 1μl
Template 1 μ l
Taq archaeal dna polymerase 0.5 μ l
Water 18.5 μ l
Above mixture totally 25 μ l carries out the PCR reaction by embodiment 1 condition.
Embodiment 6 reorganization methanol yeast bacterial strains are expressed the D-amino-acid oxidase
Select single bacterium colony from the YPD slant medium, insert the 250ml that contains the 30mlBMGY substratum and shake bottle, 28-30 ℃, 220r/min, cultivate 24h, get 1.5ml and change 40ml basis salt culture medium growth 24h over to, centrifugal (4000rpm, 5min), abandon supernatant, thalline suspends with the 40ml inducing culture, cultivates.Every 6h gets thalline and surveys the DAAO vigor, and it is 0.5% that every 24h mends methyl alcohol to its final concentration.
The pichia spp recombinant bacterial strain is expressed the D-amino-acid oxidase in embodiment 7 fermentor tanks
Fermentor tank is that the Bio F110 of U.S. NBS company controls fermentation system automatically, contains that pH regulates automatically, temperature is controlled automatically, dissolved oxygen monitoring, stirring, inlet system.
Fermentation parameter is provided with temperature: 30 ℃; PH:6.0; D0 (oxyty): 35%; Stir: 200-800r/min.
The seed liquor preparation: select single bacterium colony from the YPD slant medium, insert the bottle that shakes that contains BMGY substratum 40ml, 28-30 ℃, 220r/min cultivates 24h, as primary seed solution.Insert BMGY 400ml with 5% inoculum size again, similarity condition is cultivated 12-14h down, to A 600About about 8, as the fermentor tank seed liquor.
Fermentation culture: the 14L fermentor tank 6L basis salt nutrient solution of packing into, seed liquor inserts fermentor tank with the inoculum size of 8-10%.The growth initial stage, stir interconnected system by dissolved oxygen, DO is maintained about 35%.Stirring reaches 800r/min, removes dissolved oxygen and stirs related.Look the DO situation that suddenly rises, stream adds 50% glycerine, stops behind the 4h.Glycerine has consumed, and begins stream and adds methyl alcohol, and flow acceleration is advisable to keep DO 35%.Timing sampling is surveyed bacterium and is heavily reached vigor, puts jar in good time, and final cell density reaches 180g/L (weight in wet base), enzyme activity 4000IU/mL.
Embodiment 8 separates and purifying D-amino-acid oxidase
The thalline of inducing the back gained is with the suspension of the phosphoric acid buffer of 3 times of volumes, and centrifugal (12000rpm, 20min), with 30% ammonium sulfate precipitation supernatant, 4 ℃ centrifugal, and (12000rpm, 20min), supernatant liquor is as the upper prop sample liquid through ultrasonic echography 16min.4 ℃.
The Ni resin chromatography column of packing into, balance back well adds sample to be separated, successively with contain 0, the phosphoric acid buffer wash-out of 5mmol/L, 50mmol/L, 100mmol/L, collect respectively and contain the albumen elutriant, SDS-PAGE detects, the result shows, contains in the elution peak of 50mmol/L imidazoles and contains target protein.
Embodiment 9 HisDAAO transform CPC-Na
Above-mentioned purified product mixes with 2% CPC-Na, and 25 ℃ of oscillatory reaction 3h detect 3hCPC-Na through HPLC and transform fully, and resultant is GL-7ACA.
Embodiment 10 DAAO vitality tests
Get nutrient solution 1ml, centrifugal, the thalline tetra-sodium damping fluid (0.05mol/L that contains 30% acetone, pHg.5) 10ml suspends again, and 30min is slightly shaken in 25 ℃ of water-baths, and is centrifugal, with the physiological saline washing, thalline adds the DL-methionine 5ml of 0.05mol/L, 37 ℃ of water-bath concussion 30min.With 10% trichoroacetic acid(TCA) 3ml termination reaction, dilute 10 times, get 1ml, add 2,4 dinitrophenyl hydrazine (0.2%) 0.4ml, leave standstill 10min, add 3mol/LNaOH 1.5ml, leave standstill 15min, the centrifuging and taking supernatant is surveyed A 550
Described unit of enzyme definition: per minute generates the DAAO that the required enzyme amount of 1umol ketone acid is defined as 1 unit,
The unit of enzyme calculation formula is vigor IU/ml=K * OD * M * 1000/30 * D
K wherein: slope of standard curve 0.592; M: extension rate; D: institute's bacteria liquid of getting long-pending (ml).
The mutator gene sequence
Organization?Applicant
----------------------
Street: No. 138, medical college road
City: Shanghai
State: Shanghai
Country: the People's Republic of China (PRC)
PostalCode:200032
PhoneNumber:64037324
FaxNumber:64037324
EmailAddress:patent@shmu.edu.cn
<110〉OrganizationName: Fudan University
Application?Project
-------------------
<120〉Title: a kind of method for preparing the D-amino-acid oxidase
<130>AppFileReference:
<140>CurrentAppNumber:
<141>CurrentFilingDate:____-__-__
Sequence
--------
<213>OrganismName:Trigonopsis?Vriabllis
<400>PreSequenceString:
ggatccatgc?accatcatca?tcatcatatg?ccggtgttgc?cggtttaact?acagctcttc
60aacttcttcg?taaaggacat?gaggttacaa?ttgtgtccga?gtttacgccc?ggtgatctta
120gtatcggata?tacctcgcct?tgggcaggtg?ccaactggct?cacattttac?gatggaggca
180agttagccga?ctacgatgcc?gtctcttatc?ctatcttgcg?agagctggct?cgaagcagcc
240ccgaggctgg?aattcgactc?atcagccaac?gctcccatgt?tctcaagcgt?gatcttccta
300aactggaagt?tgccatgtcg?gccatctgtc?aacgcaatcc?ctggttcaaa?aacacagtcg
360attctttcga?gattatcgag?gacaggtcca?ggattgtcca?cgatgatgtg?gcttatctag
420tcgaatttcg?ttccgtttgt?atccacaccg?gagtctactt?gaactggctg?atgtcccaat
480gcttatcgct?cggcgccacg?gtggttaaac?gtcgagtgaa?ccatatcaag?gatgccaatt
540tactacactc?ctcaggatca?cgccccgacg?tgattgtcaa?ctgtagtggt?aaacgtcgag
600tgaaccatat?caaggatgcc?aatttactac?actcctcagg?atcacgcccc?gacgtgattg
660tcaactgtag?tggtctcttt?gcccggttct?tgggaggcgt?cgaggacaag?aagatgtacc
720ctattcgagg?acaagtcgtc?cttgttcgaa?actctcttcc?ttttatggcc?tccttttcca?780gcactcctga
aaaagaaaat?gaagacgaag?ctctatatat?catgacccga?ttcgatggta?840cttctatcat?tggcggttgt
ttccaaccca?acaactggtc?atccgaaccc?gatccttctc?900tcacccatcg?aatcctgtct?agagccctcg
accgattccc?ggaactgacc?aaagatggcc?960ctcttgacat?tgtgcgcgaa?tgcgttggcc
accgtcctgg?tagagagggc?ggtccccgag?1020tagaattaga?gaagatcccc?ggcgttggct
ttgttgtcca?taactatggt?gccgccggtg?1080ctggttacca?atcctcttac?ggcatggctg?atgaagctgt
ttcttacgtc?gaaagagctc?1140ttactcgtcc?aaacctttag?aaatcatggt?agtagtagta?gtagtaattc
gccggcg?1197
<212>Type:DNA
<211>Length:1197
SequenceName: sudden change daao gene

Claims (7)

1, a kind of method for preparing the D-amino-acid oxidase is characterized in that daao gene is modified the back transforms methanol yeast host bacterium, realizes that mutant enzyme efficiently expresses, with affinity chromatography separating and purifying high-purity D-amino-acid oxidase, comprise the steps,
1) sudden change daao gene,
With plasmid pPIC3.5K-DAAO is template, holds the Histag sequence that imports 6 Histidines of continuous programming code at the 5 ' end and 3 ' of DAAO encoding sequence, obtains mutator gene;
2) make up the mutant enzyme expression strain,
The mutator gene flush end of step 1) is cloned into pBluescript (SK+), cut rear clone to carrier pPIC3.5K through Not I and BamH I enzyme, get recombinant plasmid pPIC3.5K-hisDAAO, the Sal I linearizing of described recombinant plasmid, electricity transforms the pichia spp host cell, PCR method, enzyme activity determination screen positive recombinant bacterial strain Fudan0112, are preserved in CGMCC, deposit number on March 3rd, 2004: CGMCC No.1103;
3) fermentation, cultivation, separation sudden change D-amino-acid oxidase,
Step 2) strain fermentation, cultivation, ultrasonic broken wall thalline, low-temperature centrifugation get supernatant as crude enzyme liquid, carry out affinity chromatography, gradient elution through the Ni post again.
2, the method for preparing the D-amino-acid oxidase according to claim 1,5 ' the end and 3 ' that it is characterized in that the gene order of described sudden change D-amino-acid oxidase is held the sequence that imports 6 Histidines of continuous programming code respectively, corresponding sudden change D-amino-acid oxidase N end and C end all have the Histidine sequence, or in 5 ' end of the sequence of described sudden change D-amino-acid oxidase or the Histag sequence that 3 ' end respectively is introduced separately into 6 Histidines, corresponding sudden change D-amino-acid oxidase N end or C end have the Histidine sequence.
3, the method for preparing the D-amino-acid oxidase according to claim 1 is characterized in that having inlayed on the genomic dna of described mutant enzyme expression strain the sudden change daao gene of His sequence.
4, the method for preparing the D-amino-acid oxidase according to claim 1 is characterized in that the structure of described mutant enzyme expression strain may further comprise the steps:
1) designs mutant primer according to the DAAO gene order of trigonopsis variabilis Trigonopsis Vriabllis and the codon of Histidine correspondence, 5 ' end and 3 ' end in gene order import the Histag sequence of 6 Histidines of continuous programming code respectively, and introduce the restriction enzyme site of Not I and BamH I correspondence respectively;
2) be template with plasmid pPIC3.5K-DAAO, pcr amplification sudden change DAAO gene imports expression vector pPIC3.5K;
3) recombinant plasmid pPIC3.5K-hisDAAO electricity transforms pichia spp host bacterium GS115, screens positive recombinant bacterial strain by PCR, enzyme activity determination.
5, the method for preparing the D-amino-acid oxidase according to claim 1, the separation method that it is characterized in that the sudden change D-amino-acid oxidase of described step 3), be to have the affine fractionation by adsorption D-amino-acid oxidase of Ni ionic specificity on Histag sequence and the affine resin by sudden change D-amino-acid oxidase N end and C end, wherein gradient be 0, the phosphoric acid buffer of 5mmol/L, 25mmol/L, 50mmol/L, 100mmol/L imidazoles, the enzyme rate of recovery is 50%.。
6, the method for preparing the D-amino-acid oxidase according to claim 1 is characterized in that the separation method of the sudden change D-amino-acid oxidase of described step 3),
7, the method for preparing the D-amino-acid oxidase according to claim 1 is characterized in that described D-amino-acid oxidase can be directly used in the catalysis cephalosporin and generate GL-7ACA, generates 7-ACA. with the coupling of GL-7-ACA acylase.
CNA2004100168259A 2004-03-09 2004-03-09 Process of preparing D-amino acid oxydase Pending CN1560229A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2004100168259A CN1560229A (en) 2004-03-09 2004-03-09 Process of preparing D-amino acid oxydase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2004100168259A CN1560229A (en) 2004-03-09 2004-03-09 Process of preparing D-amino acid oxydase

Publications (1)

Publication Number Publication Date
CN1560229A true CN1560229A (en) 2005-01-05

Family

ID=34440673

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004100168259A Pending CN1560229A (en) 2004-03-09 2004-03-09 Process of preparing D-amino acid oxydase

Country Status (1)

Country Link
CN (1) CN1560229A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007051355A1 (en) * 2005-11-07 2007-05-10 Bioright Worldwide Company Limited The use of recombinant d-amino acid oxidase
WO2007090317A1 (en) * 2006-02-10 2007-08-16 Taiwan Advance Bio-Pharm Inc. A method for the production of the recombinant hoxb4 protein containing his tag at c-terminal and use thereof
CN100342002C (en) * 2005-08-12 2007-10-10 中国科学院上海生命科学研究院 Secretion type Pichi strain and its construction method
CN102513065A (en) * 2011-12-16 2012-06-27 江南大学 Flavoenzyme affinity medium and synthesis and application thereof
CN103710361A (en) * 2013-07-12 2014-04-09 广西大学 Gene daoE encoding D-amino acid oxidase, and application thereof
CN108707591A (en) * 2018-06-07 2018-10-26 东阳市人民医院 A kind of preparation and purification method and its application of DAO albumen

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100342002C (en) * 2005-08-12 2007-10-10 中国科学院上海生命科学研究院 Secretion type Pichi strain and its construction method
WO2007051355A1 (en) * 2005-11-07 2007-05-10 Bioright Worldwide Company Limited The use of recombinant d-amino acid oxidase
WO2007090317A1 (en) * 2006-02-10 2007-08-16 Taiwan Advance Bio-Pharm Inc. A method for the production of the recombinant hoxb4 protein containing his tag at c-terminal and use thereof
CN102513065A (en) * 2011-12-16 2012-06-27 江南大学 Flavoenzyme affinity medium and synthesis and application thereof
CN103710361A (en) * 2013-07-12 2014-04-09 广西大学 Gene daoE encoding D-amino acid oxidase, and application thereof
CN103710361B (en) * 2013-07-12 2015-07-15 广西大学 Gene daoE encoding D-amino acid oxidase, and application thereof
CN108707591A (en) * 2018-06-07 2018-10-26 东阳市人民医院 A kind of preparation and purification method and its application of DAO albumen

Similar Documents

Publication Publication Date Title
CN111763678B (en) Promoter for improving activity of heterologous expression enzyme of keratinase
CN1974601A (en) New-type Fc fusion protein and its production process
CN1560229A (en) Process of preparing D-amino acid oxydase
CN1793375A (en) Yeast expressing system of recombined human nerve growth factor and process for preparing recombined human nerve grouth factor
CN107794275A (en) The recombinant yeast pichia pastoris of one kind production (+) gamma-lactams enzyme and its construction method and application
CN1884501A (en) Glutamine synthetase and its dedicated expression engineered bacteria and uses
CN1693466A (en) Engineering bacteria for producing 5-amino acetyl propionic acid and its constructing method
CN1766098A (en) A kind of mannase and encoding gene thereof and application
CN1796561A (en) Recombined aminotransierase gene of glutamine of microbe, and preparation method
CN1105727C (en) Process for preparing recombined human serum albumin
CN1873006A (en) Method for producing recombined human proinsulin
CN1273585C (en) Cytochrome P450BM-3 monooxygehase varient gene and its use
CN101037692A (en) Method for expressing human insulin by using plant seed oil body
CN1916024A (en) Constructing mutant sequence of high relative quick alphd-2b interferon, expression plasmid of yeast, strain filtration, and purification method
CN1141378C (en) High-efficient expression D-amino acid oxidase methanol yeast, its construction and fermentation method
CN1181199C (en) Lichenized bacillus L-25 keratinase and its encoding DNA
CN1455001A (en) Exendin-4 polypeptide preparation method
CN1163608C (en) Procaryon secreted expression carrier and its use
CN1268750C (en) P450BM-3 variant gene for catalyzing indigo blue generated by benzazole and and use thereof
CN1076487A (en) New microorganism and prepare the method for d-vitamin H with described microorganism
CN1268751C (en) Purification method of recombinant yeast strain and rhGM-CSF to express human granulocyte-macrophage colony stimulating factor
CN1283800C (en) P450BM-3Glu435 Asp varient gene capable of catalyzing indole to generate indigo blue and its use
CN101045923A (en) Process of producing interleukin analog
CN1854296A (en) Production of recombinant human interferon beta
CN1818068A (en) Construction of recombinant human leucocyte medium-2(125ser) expression carrier

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication